All Categories
Industry Information

Home / News & Event / Industry Information

‚ÄčAnalysis Of The Development Status Of High-end Medical Device Industry


1. Definition of high-end medical devices

Medical devices refer to instruments, equipment, appliances, in vitro diagnostic reagents and calibrators, materials, and other similar or related items that are directly or indirectly used in the human body, including required computer software, the utility of which is mainly obtained through physical means.

The high-end medical device industry involves many industries such as medicine, machinery, electronics, and plastics. It is a multidisciplinary, knowledge-intensive, and capital-intensive high-tech industry. At present, my country's high-end medical devices are mainly divided into four categories: imaging equipment, therapeutic equipment, in vitro diagnostics and implanted interventional products, which are characterized by a large amount of use, a wide range of applications, and high technical content.


2, the development status of high-end medical device industry

1). Market size of medical device industry

With the normalization of domestic epidemic prevention and control and the continuous improvement of people's quality of life, my country's medical device industry has developed rapidly. The data shows that from 2017 to 2021, the market scale of my country's medical device industry continues to increase, from 443.5 billion yuan to 964 billion yuan, with an average annual compound growth rate of 21.4%. It is estimated that in 2022, the market size of China's medical device industry will reach 1.171 trillion yuan, a year-on-year increase of 21.47%.

2). Market size of high-value medical devices

High-value medical devices include high-value consumables and in vitro diagnostic reagents used in ophthalmology, orthopedics, neurointerventional, and cardiac interventional medical professions. The production and use of such consumable medical devices must be strictly controlled and limited to certain specialties. Therefore, The price is relatively high. Data show that in 2020, the market size of China's high-value medical devices is 257.500 billion yuan, a year-on-year increase of 19.5%. It is estimated that the size of China's high-value medical device market will reach 325.725 billion yuan in 2022.

3). The number of magnetic resonance imaging equipment

Magnetic resonance imaging (MRI) mainly uses magnetic resonance phenomena to obtain electromagnetic signals from the human body and reconstruct human body information. Data show that in 2020, the market share of superconducting magnetic resonance equipment in my country will reach 10,713 units, a year-on-year increase of 4.3%. Among them, from 2018 to 2020, the number of newly planned 1.5T and above magnetic resonance imaging systems in the country is 5,138. The China Business Industry Research Institute predicts that in 2022, the market share of superconducting magnetic resonance equipment in my country will reach 12,711 units.

4.) Surgical robot market size

Surgical robots are mainly used in the field of micro-traumatic surgery to achieve precise manipulation of surgical instruments that is higher than human capabilities. They have high clinical value and can effectively improve the accuracy and stability of surgery, shorten the postoperative recovery period of patients, and reduce the occurrence of complications. Data show that the size of my country's surgical robot market has grown from US$131 million in 2017 to US$755 million in 2021. It is expected that the growth trend will continue in 2022, and the market size of surgical robots will further reach USD 1.137 billion.

5). In vitro diagnostic market size

In vitro diagnosis refers to a method of obtaining clinical diagnostic information by testing human body fluids, cells and tissue samples in vitro, and then judging diseases or body functions. It is an indispensable part of the medical system to ensure human health. Data show that the scale of my country's in vitro diagnostics market has grown from 56.8 billion yuan in 2017 to 124.3 billion yuan in 2021, with an average annual compound growth rate of 21.6%. It is expected that in 2022, my country's in vitro diagnostic market will continue to grow, and the market size will reach 146 billion yuan.

6). Coronary Interventional Devices Market Scale

Coronary interventional therapy (PCI) is mainly performed by puncturing the surface blood vessels, sending it into a cardiac catheter under continuous projection of digital subtraction, and using specific catheter operation techniques to diagnose and treat patients. Data show that in 2020, the market size of my country's coronary intervention device market will reach 6.41 billion yuan, a year-on-year increase of 3.7%. It is expected that the market size of coronary interventional devices in my country will maintain a growing trend. By 2022, the market size of coronary interventional devices in my country will reach 7.39 billion yuan.

7). Market size of peripheral vascular interventional devices

The data shows that the market size of peripheral vascular interventional devices in my country increased from 1.81 billion in 2017 to 2.49 billion in 2019, with a compound annual growth rate of 19.3%. In 2020, due to the impact of the new crown pneumonia epidemic, the market size has declined. It is expected that the market size of peripheral vascular interventional devices will reach 3.25 billion yuan in 2022.

3. The market size of the global high-value medical device industry is about 80 billion US dollars

The development of the global high-value medical device industry is a tributary of the development of the medical device industry, and the high price of high-value medical devices is mainly determined by technology and cost. With the development of the overall medical device industry and the advancement of medical level, the development of the global medical high-value device industry has experienced four stages: "simple medical device", "medical electronics", "medical engineering" and "biomedicine".

At present, benefiting from the development of the global economic level, the demand for medical consumption is increasing, and the global high-value medical device market has also ushered in huge development opportunities. According to estimates, the market size of the global high-value medical device industry in 2020 is about 80 billion US dollars (calculated exchange rate: 1 US dollar = 6.5 RMB).

Regional Competitive Landscape: The U.S. Remains a Global Leader

From a regional perspective, the United States is both the world's largest producer and largest consumer of medical devices. From the "2020 Top 100 Medical Device Companies List" released by QMED, it can be seen that a total of 48 companies in the United States have entered the top 100 list, accounting for 48% of the global top 100 medical device companies. Next is Japan, with 11 companies on the list accounting for 11%; China has 7 companies in the top 100, accounting for 7%. It can be seen that the United States is still a global leader in the high-value medical device industry.

Brand competition pattern: leading brands are all Western leading companies

Since most of the leading high-value medical device companies are comprehensive medical device manufacturers, it is difficult to divest their specific business proportions. Therefore, the industry competition pattern can be seen from the market share of the global medical device industry. It can be seen that the global medical device industry is still dominated by leading companies in western developed countries. Medtronic, Johnson & Johnson and Siemens are the top three in the industry, accounting for 5.9%, 4.7% and 2.9% of the industry market share.

4, medical device imports replace external driving factors

1). The incidence of diseases in my country is mostly on the rise, especially the incidence of orthopedic diseases involving high-value orthopedic consumables increases with age

The segment with the highest proportion of medical devices in my country's medical insurance catalogue is orthopedic consumables. According to the 2020 China Health and Health Statistical Yearbook, the incidence of orthopedic diseases in my country over the age of 60 is generally high in 2019, with the highest incidence of bone mineral density and Bone structure disease, 83.2%. And my country is currently in an aging stage. According to the data of the seventh census, my country has a population of 264 million people over the age of 60. Therefore, vigorously promoting localization has a positive impact on saving my country's medical insurance funds.

2). Driven by information security demands

Article 49 of the Basic Medical and Health Promotion Law of the People's Republic of China states: "The state promotes the informatization of national health, promotes the application and development of health care big data and artificial intelligence, accelerates the construction of medical and health information infrastructure, and formulates health The technical standards for the collection, storage, analysis and application of medical data, and the use of information technology to promote the popularization and sharing of high-quality medical and health resources. The people's governments at or above the county level and their relevant departments should take measures to promote the use of information technology in the medical and health field and medical education. support the exploration and development of new models and formats of medical and health services.

The state takes measures to promote medical and health institutions to establish and improve medical and health information exchange and information security systems, apply information technology to carry out telemedicine services, and build an online and offline integrated medical service model. "The above measures will become the focus of domestic hospital informatization construction during the "14th Five-Year Plan" period. Domestic tertiary hospitals and qualified secondary hospitals should complete the information platform construction during the "14th Five-Year Plan" period, in order to realize the construction of Internet hospitals and smart hospitals. , information interconnection and the application of a new generation of information technology, etc., and strive to break the "information island" as soon as possible.

On the other hand, the interconnection and open sharing of medical and health information has put forward higher requirements for information security and privacy protection. The personal information, sensitive information and private information in the digital result data are more comprehensive and accurate, and the data security of health and medical institutions Sex has become the biggest appeal, which is conducive to accelerating the entry of domestic devices into medical institutions.

3). Relevant policy drivers

In recent years, my country's medical device industry is ushering in a rare "policy-intensive period". From "Made in China 2025" to "Healthy China 2030 Planning Outline", the localization of high-end medical devices has been pushed to an unprecedented national strategic height.

the new medical reform drives medical institutions to purchase domestic medical devices. For a long time, the high prices of foreign brands and the "overlord clauses" in the after-sales maintenance and other links have forced hospitals to transfer costs to patients.

After the promulgation of the new round of medical reform plan, the policy has forced public hospitals to curb the unreasonable growth of inspection fees and medical expenses, and the use of cost-effective domestic medical devices will become an important means to reduce inspection costs. The third is hierarchical diagnosis and treatment to promote the application of domestic medical devices. Hierarchical diagnosis and treatment is another important part of the new round of medical reform, and the action to improve the level of primary medical services is accelerating. Affected by this favorable policy, the demand for cost-effective domestic medical devices in primary medical institutions will grow rapidly.

Under the continuous promotion of policies, more and more high-quality domestic devices are entering the market, and the market share of domestic brands is also expanding. The basic medical device products that mainly relied on imports in the past have basically achieved localization, and import substitution has gradually been introduced in the low-end market. to the high-end market.

Have Questions about Arshine Lifescience?

Our professional sales team are waiting for your consultation.